# Janus International Group, Inc.: financial statements, quarterly

JBI · NYSE · CIK 1839839 · [Industrials](/sectors/industrials.md) · fiscal year ends Jan 1

Pages: [Overview](/companies/jbi.md) · [Financials](/companies/jbi/financials.md) · [Filings](/companies/jbi/filings.md) · [Insiders](/companies/jbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/jbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [280](/filings/0001839839-24-000212.md) | [264 d](/filings/0001839839-26-000006.md) | [255](/filings/0001839839-25-000132.md) | [248](/filings/0001839839-25-000141.md) | [230](/filings/0001839839-25-000150.md) | [231 d](/filings/0001839839-26-000006.md) | [211](/filings/0001839839-26-000012.md) | [228](/filings/0001839839-26-000018.md) | [219](/filings/0001839839-25-000150.md) | [226 d](/filings/0001839839-26-000006.md) | [223](/filings/0001839839-26-000012.md) | [234](/filings/0001839839-26-000018.md) |
| Cost of revenue | $m | [161](/filings/0001839839-24-000212.md) | [149 d](/filings/0001839839-26-000006.md) | [144](/filings/0001839839-25-000132.md) | [139](/filings/0001839839-25-000141.md) | [139](/filings/0001839839-25-000150.md) | [144 d](/filings/0001839839-26-000006.md) | [129](/filings/0001839839-26-000012.md) | [135](/filings/0001839839-26-000018.md) | [134](/filings/0001839839-25-000150.md) | [144 d](/filings/0001839839-26-000006.md) | [148](/filings/0001839839-26-000012.md) | [153](/filings/0001839839-26-000018.md) |
| Gross profit | $m | [119](/filings/0001839839-24-000212.md) | [114 d](/filings/0001839839-26-000006.md) | [110](/filings/0001839839-25-000132.md) | [109](/filings/0001839839-25-000141.md) | [91.2](/filings/0001839839-25-000150.md) | [87.2 d](/filings/0001839839-26-000006.md) | [81.9](/filings/0001839839-26-000012.md) | [93.2](/filings/0001839839-26-000018.md) | [85.7](/filings/0001839839-25-000150.md) | [82.2 d](/filings/0001839839-26-000006.md) | [75.2](/filings/0001839839-26-000012.md) | [80.3](/filings/0001839839-26-000018.md) |
| Operating income | $m | [66.5](/filings/0001839839-24-000212.md) | [63.9 d](/filings/0001839839-26-000006.md) | [55.5](/filings/0001839839-25-000132.md) | [51.6](/filings/0001839839-25-000141.md) | [26.7](/filings/0001839839-25-000150.md) | [12.8 d](/filings/0001839839-26-000006.md) | [25.3](/filings/0001839839-26-000012.md) | [36.0](/filings/0001839839-26-000018.md) | [29.4](/filings/0001839839-25-000150.md) | [20.8 d](/filings/0001839839-26-000006.md) | [13.1](/filings/0001839839-26-000012.md) | [20.6](/filings/0001839839-26-000018.md) |
| Interest expense | $m | [14.5](/filings/0001839839-23-000117.md) | [14.7 d](/filings/0001839839-24-000066.md) | [14.4](/filings/0001839839-24-000143.md) | [13.0](/filings/0001839839-25-000141.md) | [11.6](/filings/0001839839-25-000150.md) | [10.7 d](/filings/0001839839-26-000006.md) | [10.2](/filings/0001839839-26-000012.md) | [9.1](/filings/0001839839-26-000018.md) | [8.7](/filings/0001839839-25-000150.md) | [8.8 d](/filings/0001839839-26-000006.md) | [8.1](/filings/0001839839-26-000012.md) | [7.4](/filings/0001839839-26-000018.md) |
| Income tax | $m | [12.4](/filings/0001839839-24-000212.md) | [13.4 d](/filings/0001839839-26-000006.md) | [10.5](/filings/0001839839-25-000132.md) | [9.5](/filings/0001839839-25-000141.md) | [3.3](/filings/0001839839-25-000150.md) | [6.6 d](/filings/0001839839-26-000006.md) | [4.6](/filings/0001839839-26-000012.md) | [6.4](/filings/0001839839-26-000018.md) | [6.1](/filings/0001839839-25-000150.md) | [5.5 d](/filings/0001839839-26-000006.md) | [2.3](/filings/0001839839-26-000012.md) | [2.4](/filings/0001839839-26-000018.md) |
| Net income | $m | [37.0](/filings/0001839839-24-000212.md) | [35.7 d](/filings/0001839839-26-000006.md) | [30.7](/filings/0001839839-25-000150.md) | [27.6](/filings/0001839839-25-000150.md) | [11.8](/filings/0001839839-25-000150.md) | [0.3 d](/filings/0001839839-26-000006.md) | [10.8](/filings/0001839839-26-000018.md) | [20.7](/filings/0001839839-26-000018.md) | [15.2](/filings/0001839839-25-000150.md) | [7.1 d](/filings/0001839839-26-000006.md) | [0.2](/filings/0001839839-26-000018.md) | [10.7](/filings/0001839839-26-000018.md) |
| Diluted EPS | $ per share | [0.25](/filings/0001839839-24-000212.md) | not reported | [0.21](/filings/0001839839-25-000132.md) | [0.19](/filings/0001839839-25-000141.md) | [0.08](/filings/0001839839-25-000150.md) | not reported | [0.08](/filings/0001839839-26-000012.md) | [0.15](/filings/0001839839-26-000018.md) | [0.11](/filings/0001839839-25-000150.md) | not reported | [0.00](/filings/0001839839-26-000012.md) | [0.08](/filings/0001839839-26-000018.md) |
| Basic EPS | $ per share | [0.25](/filings/0001839839-24-000212.md) | not reported | [0.21](/filings/0001839839-25-000132.md) | [0.19](/filings/0001839839-25-000141.md) | [0.08](/filings/0001839839-25-000150.md) | not reported | [0.08](/filings/0001839839-26-000012.md) | [0.15](/filings/0001839839-26-000018.md) | [0.11](/filings/0001839839-25-000150.md) | not reported | [0.00](/filings/0001839839-26-000012.md) | [0.08](/filings/0001839839-26-000018.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [110](/filings/0001839839-23-000117.md) | [172](/filings/0001839839-24-000212.md) | [178](/filings/0001839839-24-000143.md) | [110](/filings/0001839839-24-000186.md) | [102](/filings/0001839839-24-000212.md) | [149](/filings/0001839839-26-000006.md) | [141](/filings/0001839839-25-000132.md) | [174](/filings/0001839839-25-000141.md) | [179](/filings/0001839839-25-000150.md) | [194](/filings/0001839839-26-000018.md) | [112](/filings/0001839839-26-000012.md) | [127](/filings/0001839839-26-000018.md) |
| Current assets | $m | [399](/filings/0001839839-23-000117.md) | [463](/filings/0001839839-25-000032.md) | [473](/filings/0001839839-24-000143.md) | [406](/filings/0001839839-24-000186.md) | [375](/filings/0001839839-24-000212.md) | [386](/filings/0001839839-26-000006.md) | [361](/filings/0001839839-25-000132.md) | [398](/filings/0001839839-25-000141.md) | [414](/filings/0001839839-25-000150.md) | [422](/filings/0001839839-26-000018.md) | [355](/filings/0001839839-26-000012.md) | [372](/filings/0001839839-26-000018.md) |
| Total assets | $m | [1,297](/filings/0001839839-23-000117.md) | [1,350](/filings/0001839839-25-000032.md) | [1,350](/filings/0001839839-24-000143.md) | [1,335](/filings/0001839839-24-000186.md) | [1,295](/filings/0001839839-24-000212.md) | [1,301](/filings/0001839839-26-000006.md) | [1,272](/filings/0001839839-25-000132.md) | [1,303](/filings/0001839839-25-000141.md) | [1,301](/filings/0001839839-25-000150.md) | [1,305](/filings/0001839839-26-000018.md) | [1,309](/filings/0001839839-26-000012.md) | [1,311](/filings/0001839839-26-000018.md) |
| Current liabilities | $m | [161](/filings/0001839839-23-000117.md) | [174](/filings/0001839839-25-000032.md) | [160](/filings/0001839839-24-000143.md) | [144](/filings/0001839839-24-000186.md) | [134](/filings/0001839839-24-000212.md) | [137](/filings/0001839839-26-000006.md) | [139](/filings/0001839839-25-000132.md) | [152](/filings/0001839839-25-000141.md) | [137](/filings/0001839839-25-000150.md) | [119](/filings/0001839839-26-000018.md) | [134](/filings/0001839839-26-000012.md) | [127](/filings/0001839839-26-000018.md) |
| Total liabilities | $m | [817](/filings/0001839839-23-000117.md) | [830](/filings/0001839839-25-000032.md) | [815](/filings/0001839839-24-000143.md) | [779](/filings/0001839839-24-000186.md) | [768](/filings/0001839839-24-000212.md) | [783](/filings/0001839839-26-000006.md) | [745](/filings/0001839839-25-000132.md) | [759](/filings/0001839839-25-000141.md) | [740](/filings/0001839839-25-000150.md) | [733](/filings/0001839839-26-000018.md) | [749](/filings/0001839839-26-000012.md) | [739](/filings/0001839839-26-000018.md) |
| Long-term debt | $m | [609](/filings/0001839839-23-000117.md) | [608](/filings/0001839839-25-000032.md) | [606](/filings/0001839839-24-000143.md) | [586](/filings/0001839839-24-000186.md) | [586](/filings/0001839839-24-000212.md) | [583](/filings/0001839839-26-000006.md) | [545](/filings/0001839839-25-000132.md) | [543](/filings/0001839839-25-000141.md) | [540](/filings/0001839839-25-000150.md) | [539](/filings/0001839839-26-000018.md) | [540](/filings/0001839839-26-000012.md) | [539](/filings/0001839839-26-000018.md) |
| Current portion of debt | $m | [7.1](/filings/0001839839-23-000117.md) | [7.3](/filings/0001839839-25-000032.md) | [7.3](/filings/0001839839-24-000143.md) | [7.3](/filings/0001839839-24-000186.md) | [7.3](/filings/0001839839-24-000212.md) | [8.8](/filings/0001839839-26-000006.md) | [7.5](/filings/0001839839-25-000132.md) | [7.5](/filings/0001839839-25-000141.md) | [8.7](/filings/0001839839-25-000150.md) | [6.9](/filings/0001839839-26-000018.md) | [6.3](/filings/0001839839-26-000012.md) | [6.1](/filings/0001839839-26-000018.md) |
| Shareholders' equity | $m | [480](/filings/0001839839-24-000212.md) | [520](/filings/0001839839-26-000006.md) | [535](/filings/0001839839-25-000150.md) | [556](/filings/0001839839-25-000150.md) | [527](/filings/0001839839-25-000150.md) | [519](/filings/0001839839-26-000018.md) | [527](/filings/0001839839-26-000018.md) | [544](/filings/0001839839-26-000018.md) | [561](/filings/0001839839-25-000150.md) | [573](/filings/0001839839-26-000018.md) | [560](/filings/0001839839-26-000018.md) | [572](/filings/0001839839-26-000018.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2026-01-03) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.9 d](/filings/0001839839-24-000212.md) | [68.5 d](/filings/0001839839-26-000006.md) | [28.6](/filings/0001839839-25-000132.md) | [31.0 d](/filings/0001839839-25-000141.md) | [43.0 d](/filings/0001839839-25-000150.md) | [51.4 d](/filings/0001839839-26-000006.md) | [48.3](/filings/0001839839-26-000012.md) | [51.4 d](/filings/0001839839-26-000018.md) | [15.0 d](/filings/0001839839-25-000150.md) | [24.8 d](/filings/0001839839-26-000006.md) | [36.2](/filings/0001839839-26-000012.md) | [24.4 d](/filings/0001839839-26-000018.md) |
| Capital expenditure | $m | [3.9 d](/filings/0001839839-24-000212.md) | [5.5 d](/filings/0001839839-26-000006.md) | [4.6](/filings/0001839839-25-000132.md) | [5.7 d](/filings/0001839839-25-000141.md) | [3.7 d](/filings/0001839839-25-000150.md) | [6.1 d](/filings/0001839839-26-000006.md) | [6.4](/filings/0001839839-26-000012.md) | [6.8 d](/filings/0001839839-26-000018.md) | [6.7 d](/filings/0001839839-25-000150.md) | [5.6 d](/filings/0001839839-26-000006.md) | [2.8](/filings/0001839839-26-000012.md) | [2.8 d](/filings/0001839839-26-000018.md) |
| Share repurchases | $m | [0.0 d](/filings/0001839839-24-000212.md) | [0.0 d](/filings/0001839839-26-000006.md) | [15.3](/filings/0001839839-25-000132.md) | [9.9 d](/filings/0001839839-25-000141.md) | [45.0 d](/filings/0001839839-25-000150.md) | [8.6 d](/filings/0001839839-26-000006.md) | [5.0](/filings/0001839839-26-000012.md) | [10.0 d](/filings/0001839839-26-000018.md) | [0.9 d](/filings/0001839839-25-000150.md) | [0.0 d](/filings/0001839839-26-000006.md) | [15.5](/filings/0001839839-26-000012.md) | [1.9 d](/filings/0001839839-26-000018.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-01) | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-04-04) | Q2 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [147](/filings/0001839839-23-000117.md) | [147](/filings/0001839839-24-000143.md) | [147](/filings/0001839839-24-000186.md) | [147](/filings/0001839839-24-000212.md) | [147](/filings/0001839839-25-000132.md) | [146](/filings/0001839839-25-000141.md) | [144](/filings/0001839839-25-000150.md) | [140](/filings/0001839839-26-000012.md) | [140](/filings/0001839839-26-000018.md) | [139](/filings/0001839839-25-000150.md) | [139](/filings/0001839839-26-000012.md) | [137](/filings/0001839839-26-000018.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 136,435,790 at 2026-08-07, from the cover of the [10-Q filed 2026-08-11](/filings/0001839839-26-000018.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.